Joselle M. Cook, M.B.B.S.

  1. Hematologist
  2. Internist
  3. Oncologist
  1. Rees MJ, Toumeh N, Dispenzieri A, Gertz M, Yohannan B, Atallah-Yunes SA, Kapoor P, Kourelis T, Leung N, Hayman S, Buadi F, Dingli D, Cook J, Warsame R, Binder M, Gonsalves W, Rajkumar SV, Kumar S, Muchtar E. Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival. Amyloid. 2025 Sep; 32 (3):267-275 Epub 2025 June 12
    View PubMed
  2. Bolarinwa A, Odukoya L, Buadi F, Rajkumar V, Kumar S, Vachon C, Paemka L, Baughn LB, Cook JM. Monoclonal Gammopathies in Africa. Clin Lymphoma Myeloma Leuk. 2025 Sep; 25 (9):e696-e703.e2 Epub 2025 May 31
    View PubMed
  3. Muchtar E, Dispenzieri A, Buadi FK, Kapoor P, Dingli D, Kourelis TV, Gonsalves W, Leung N, Hayman SR, Lacy MQ, Siddiqui M, Cook J, Abdallah N, Binder M, Zanwar S, Hogan W, Warsame R, Rajkumar SV, Kumar SK, Gertz MA. From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis. Blood Adv. 2025 Aug 26; 9 (16):4311-4316
    View PubMed
  4. Askari E, Dispenzieri A, Buadi FK, Hayman SR, Gertz MA, Kapoor P, Gonsalves W, Kourelis T, Dingli D, Warsame R, Leung N, Lin Y, Muchtar E, Cook J, Binder M, Abdallah N, Hwa L, Hobbs M, Fonder A, Murray D, Kyle RA, Vincent Rajkumar S, Kumar SK. Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis. Blood Cancer J. 2025 Aug 7; 15 (1):133 Epub 2025 Aug 07
    View PubMed
  5. Cook J, Warsame R, Omar M, Buadi FK, Abdallah N, Dingli D, Hayman SR, Kapoor P, Kourelis T, Binder M, Muchtar E, Fonder A, Hwa YL, Hobbs MA, Lin Y, Gonsalves WI, Gertz MA, Kumar SK, Rajkumar SV, Dispenzieri A. Interleukin-6 is a highly prognostic biomarker for POEMS syndrome. Leukemia. 2025 Jul 11 Epub 2025 July 11
    View PubMed
  6. Rees MJ, Geyer S, Yohannan B, Toumeh N, Atallah-Yunes SA, Gertz MA, Dispenzieri A, Hayman SR, Buadi F, Dingli D, Warsame R, Kapoor P, Grogan M, Cook J, Binder M, Leung N, Kourelis T, Gonsalves W, Rajkumar VS, Kumar S, Muchtar E. Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response. Haematologica. 2025 May 22 [Epub ahead of print]
    View PubMed
  7. Dingli S, Rothweiler P, Binder M, Cook J, Gertz MA, Hayman S, Kapoor P, Kourelis T, Kumar SK, Siddiqui M, Warsame R, Lin Y, Erdman AG, Dingli D. The ratio of brain to liver glucose activity and disease activity in multiple myeloma. Blood Cancer J. 2025 May 7; 15 (1):90 Epub 2025 May 07
    View PubMed
  8. Yohannan B, Rees M, Gertz MA, Dispenzieri A, Kapoor P, Buadi FK, Dingli D, Leung N, Lacy MQ, Hayman SR, Gonsalves W, Kourelis T, Cook J, Binder M, Siddiqui M, Lin Y, Hwa L, Rogers MG, Hobbs M, Fonder A, Warsame R, Rajkumar SV, Kumar SK, Muchtar E. Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis. Blood Neoplasia. 2025 May; 2 (2):100092 Epub 2025 Mar 10
    View PubMed
  9. Puttkammer JR, Barreto JN, Jensen CJ, Nedved AN, Wilson-Miller JL, Cole KC, Holmes LM, Kosobud AR, Kapoor P, Gertz MA, Dingli D, Gonsalves WI, Kumar SK, Hayman SR, Kourelis TV, Warsame R, Binder M, Cook J, Lin Y, Sandahl TB. Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization. JCO Oncol Pract. 2025 Apr 15; OP2400930 [Epub ahead of print]
    View PubMed
  10. Charalampous C, Claveau JS, Kapoor P, Binder M, Buadi FK, Cook J, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves W, Hayman SR, Hobbs MA, Christenson LH, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes. Blood Adv. 2025 Apr 8; 9 (7):1559-1570
    View PubMed
  11. Bolarinwa A, Nagaraj M, Zanwar S, Abdallah N, Bergsagel PL, Binder M, Buadi F, Chhabra S, Cook J, Dingli D, Dispenzieri A, Gertz MA, Gonsalves W, Hayman S, Kapoor P, Kourelis T, Leung N, Lin Y, Muchtar E, Parrondo R, Roy V, Sher T, Siddiqui M, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Yadav U, Wiedmeier-Nutor JE, Baughn LB, Vincent Rajkumar S, Fonseca R, Ailawadhi S, Kumar S. Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes. Blood Cancer J. 2025 Apr 4; 15 (1):57 Epub 2025 Apr 04
    View PubMed
  12. Dingli S, Rothweiler P, Binder M, Cook J, Gertz MA, Hayman S, Kapoor P, Kourelis T, Kumar SK, Siddiqui M, Warsame R, Lin Y, Erdman AG, Dingli D. Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma. Leukemia. 2025 Apr; 39 (4):1005-1008 Epub 2025 Mar 05
    View PubMed
  13. Faruqi AJ, Nguyen GH, Cook J. Acrokeratosis Paraneoplastica Due to Monoclonal Gammopathy. Mayo Clin Proc. 2025 Apr; 100 (4):747-748 Epub 2025 Mar 08
    View PubMed
  14. Abdallah N, Dizona P, Kumar A, LaPlant B, Menser T, Schaeferle G, Aug S, Weivoda M, Dispenzieri A, Buadi FK, Warsame R, Cook J, Lacy MQ, Hayman S, Gertz MA, Rajkumar SV, Kumar SK. Cumulative deficits frailty index and relationship status predict survival in multiple myeloma. Blood Adv. 2025 Mar 11; 9 (5):1137-1146
    View PubMed
  15. Lee K, Kourelis T, Tschautscher M, Warsame R, Buadi F, Gertz M, Muchtar E, Dingli D, Hayman S, Go R, Hwa L, Fonder A, Gonsalves W, Hobbs M, Kyle R, Kapoor P, Leung N, Binder M, Cook J, Lin Y, Rogers M, Rajkumar SV, Kumar S, Dispenzieri A. Capillary leak phenotype as a major cause of death in patients with POEMS syndrome. Leukemia. 2025 Mar; 39 (3):703-709 Epub 2024 Dec 16
    View PubMed
  16. Abdallah N, Bohra A, Mammadzadeh A, Buadi F, Kapoor P, Dispenzieri A, Gertz M, Hayman S, ElHaj M, Dingli D, Cook J, Binder M, Lin Y, Kourelis T, Warsame R, Thompson C, Menser T, Rajkumar SV, Kumar S. Prognostic impact of patient-reported symptoms in multiple myeloma. Blood Adv. 2025 Feb 25; 9 (4):884-892
    View PubMed
  17. Zanwar S, Jevremovic D, Kapoor P, Olteanu H, Buadi F, Horna P, Gonsalves W, Otteson G, Bolarinwa AB, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Gertz MA, Kourelis T, Leung N, Lin Y, Muchtar E, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Kyle RA, Rajkumar SV, Kumar S. Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma. Blood Cancer J. 2025 Feb 18; 15 (1):20
    View PubMed
  18. Price KA, Warsame R, Toure EA, O'Shea M, Kim YH, Ellingson SA, Cook JM, Asiedu GB. Qualitative Study of Health Care Professional Perspectives on Recruiting Minority Patients in Cancer Trials. Health Equity. 2025; 9 (1):53-59 Epub 2025 Jan 20
    View PubMed
  19. Essiaw LA, Bolarinwa A, Tang H, Kudowor G, Shivaram S, Sharma N, Linden MA, Buadi FK, Rajkumar SV, Kumar S, Dei-Adomakoh Y, Cook JM, Baughn LB, Paemka L. Comparison of Laboratory Data at Initial Diagnosis of Multiple Myeloma Between Black Africans, African Americans and White patients. Clin Lymphoma Myeloma Leuk 2024 Dec; 24 (12):863-868 Epub 2024 July 17
    View PubMed
  20. Chohan KL, Pruthi RK, Zanwar S, Paludo J, Go R, Pardanani A, Ashrani A, Cook JM, Thompson CA, Chanan-Khan A, Ailawadhi S, Habermann TM, Witzig TE, Gertz MA, Dingli D, Buadi FK, Dispenzieri A, Leung N, Kumar SK, Rajkumar V, Nichols WL, Kyle RA, Ansell SM, Kapoor P, Sridharan M, Abeykoon JP. The clinical impact of acquired von Willebrand syndrome secondary to Waldenstrom macroglobulinemia: an underrecognized source of major bleeding events. Leukemia. 2024 Nov; 38 (11):2497-2500 Epub 2024 Aug 28
    View PubMed
  21. El Sadaney AO, Dutta A, Cook J, Baffour FI. Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging. Diagnostics (Basel). 2024 Aug 29; 14 (17)
    View PubMed
  22. Zanwar S, Le-Rademacher J, Durot E, D'Sa S, Abeykoon JP, Mondello P, Kumar S, Sarosiek S, Paludo J, Chhabra S, Cook JM, Parrondo R, Dispenzieri A, Gonsalves WI, Muchtar E, Ailawadhi S, Kyle RA, Rajkumar SV, Delmer A, Fonseca R, Gertz MA, Treon SP, Ansell SM, Castillo JJ, Kapoor P. Simplified Risk Stratification Model for Patients With Waldenstrom Macroglobulinemia. J Clin Oncol. 2024 Jul 20; 42 (21):2527-2536 Epub 2024 May 24
    View PubMed
  23. Zanwar S, Gertz MA, Muchtar E, Buadi FK, Kourelis T, Gonsalves W, Go RS, Hayman S, Kapoor P, Binder M, Cook J, Dingli D, Leung N, Lin Y, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S, Dispenzieri A. Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures. Leukemia 2024 Jun; 38 (6):1423-1426 Epub 2024 Apr 09
    View PubMed
  24. Abdallah NH, Lakshman A, Kumar SK, Cook J, Binder M, Kapoor P, Dispenzieri A, Gertz MA, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Lin Y, Kourelis T, Warsame R, Bergsagel L, Rajkumar SV. Mode of progression in smoldering multiple myeloma: a study of 406 patients. Blood Cancer J. 2024 Jan 17; 14 (1):9
    View PubMed
  25. Charalampous C, Goel U, Kapoor P, Binder M, Buadi FK, Cook J, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves W, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma. Blood Cancer J 2023 Dec 11; 13 (1):183
    View PubMed
  26. Yadav U, Kumar SK, Baughn LB, Dispenzieri A, Greipp P, Ketterling R, Jevremovic D, Buadi FK, Dingli D, Lacy MQ, Fonseca R, Bergsagel PL, Ailawadhi S, Roy V, Parrondo R, Sher T, Hayman SR, Kapoor P, Leung N, Cook J, Binder M, Muchtar E, Warsame R, Kourelis TV, Go RS, Lin Y, Seth A, Lester SC, Breen WG, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas. Blood. 2023 Nov 30; 142 (22):1871-1878
    View PubMed
  27. Pitel BA, Zepeda-Mendoza C, Sachs Z, Tang H, Shivaram S, Sharma N, Smadbeck JB, Smoley SA, Pearce KE, Luoma IM, Cook J, Litzow MR, Hoppman NL, Viswanatha D, Xu X, Ketterling RP, Greipp PT, Peterson JF, Baughn LB. Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia. Blood Cancer J 2023 Sep 6; 13 (1):138 Epub 2023 Sept 06
    View PubMed
  28. Charalampous C, Goel U, Kapoor P, Binder M, Buadi FK, Cook J, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves W, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy. Blood Adv. 2023 Aug 22; 7 (16):4371-4380
    View PubMed
  29. Charalampous C, Goel U, Kapoor P, Binder M, Buadi FK, Cook J, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves W, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy. Blood Adv. 2023 Aug 22; 7 (16):4371-4380
    View PubMed
  30. Schmidt WM, Perera ND, Buadi FK, Hayman SR, Kumar SK, Dispenzieri A, Dingli D, Cook J, Lacy MQ, Kapoor P, Leung N, Muchtar E, Warsame RM, Kourelis T, Binder M, Gonsalves WI, Hogan WJ, Gertz MA. Long-term outcomes of allogeneic stem cell transplant in multiple myeloma. Blood Cancer J. 2023 Aug 18; 13 (1):126
    View PubMed
  31. Visram A, Hayman SR, Dispenzieri A, Kapoor P, Lacy MQ, Gertz MA, Buadi FK, Dingli D, Warsame R, Kourelis T, Cook J, Binder M, Gonsalves W, Muchtar E, Leung N, Roy V, Rajkumar SV, Kumar S. A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL). Am J Hematol. 2023 Aug; 98 (8):1277-1285 Epub 2023 June 19
    View PubMed
  32. Baughn LB, Jessen E, Sharma N, Tang H, Smadbeck JB, Long MD, Pearce K, Smith M, Dasari S, Sachs Z, Linden MA, Cook J, Keith Stewart A, Chesi M, Mitra A, Leif Bergsagel P, Van Ness B, Kumar SK. Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood Cancer J. 2023 May 22; 13 (1):84
    View PubMed
  33. Cook J, Rajendran K, Ferrero A, Dhillon P, Kumar S, Baffour F. Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation. Acta Haematol. 2023; 146 (5):419-423 Epub 2023 June 20
    View PubMed
  34. Baffour FI, Huber NR, Ferrero A, Rajendran K, Glazebrook KN, Larson NB, Kumar S, Cook JM, Leng S, Shanblatt ER, McCollough CH, Fletcher JG. Photon-counting Detector CT with Deep Learning Noise Reduction to Detect Multiple Myeloma. Radiology. 2023 Jan; 306(1):229-236. Epub 2022 Sep 06.
    View PubMed
  35. Ebraheem M, Kumar SK, Dispenzieri A, Jevremovic D, Buadi FK, Dingli D, Cook J, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Binder M, Lin Y, Go RS, Siddiqui MA, Kyle RA, Rajkumar SV, Gonsalves WI, Gertz MA. Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy. Transplant Cell Ther. 2022 Nov; 28 (11):760.e1-760.e5 Epub 2022 Aug 05
    View PubMed
  36. Warsame R, Cook J, Fruth B, Hubbard J, Croghan K, Price KAR, Jatoi A, Kumar S, Thompson C, Buckner J, Dispenzieri A, Sloan J, Dueck AC. A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology. Contemp Clin Trials Commun. 2022 Oct; 29:100964 Epub 2022 July 13
    View PubMed
  37. Gong H, Baffour FI, Glazebrook KN, Rhodes NG, Tiegs-Heiden CA, Thorne JE, Cook JM, Kumar S, Fletcher JG, McCollough CH, Leng S. Deep learning-based virtual noncalcium imaging in multiple myeloma using dual-energy CT. Med Phys. 2022 Oct; 49 (10):6346-6358 Epub 2022 Aug 28
    View PubMed
  38. Cook J, Peng KW, Witzig TE, Broski SM, Villasboas JC, Paludo J, Patnaik M, Rajkumar V, Dispenzieri A, Leung N, Buadi F, Bennani N, Ansell SM, Zhang L, Packiriswamy N, Balakrishnan B, Brunton B, Giers M, Ginos B, Dueck AC, Geyer S, Gertz MA, Warsame R, Go RS, Hayman SR, Dingli D, Kumar S, Bergsagel L, Munoz JL, Gonsalves W, Kourelis T, Muchtar E, Kapoor P, Kyle RA, Lin Y, Siddiqui M, Fonder A, Hobbs M, Hwa L, Naik S, Russell SJ, Lacy MQ. Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma. Blood Adv. 2022 Jun 14; 6 (11):3268-3279
    View PubMed
  39. Cook J, Gonsalves WI, Gertz MA, Visram A, Warsame R, Lacy MQ, Dispenzieri A, Dingli D, Kapoor P, Kourelis TV, Hayman SR, Kyle RA, Muchtar E, Kumar SK, Hogan WJ, Jacob EK, Buadi FK. Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis. Bone Marrow Transplant 2022 Jun; 57 (6):1007-1009 Epub 2022 Apr 02
    View PubMed
  40. Audil HY, Cook JM, Greipp PT, Kapoor P, Baughn LB, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Muchtar E, Siddiqui M, Gonsalves WI, Hwa YL, Leung N, Lin Y, Kourelis TV, Warsame R, Kyle RA, Ketterling RP, Rajkumar SV, Kumar SK. Prognostic significance of acquired 1q22 gain in multiple myeloma. Am J Hematol. 2022 Jan 1; 97 (1):52-59 Epub 2021 Nov 03
    View PubMed
  41. Visram A, Cook J, Warsame R. Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies. Hematology Am Soc Hematol Educ Program. 2021 Dec 10; 2021 (1):673-681
    View PubMed
  42. Warsame RM, Asiedu GB, Kumbamu A, Cook J, Hayes SN, Thompson CA, Hobday TJ, Price KAR. Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program. JAMA Netw Open. 2021 Nov 1; 4 (11):e2133199 Epub 2021 Nov 01
    View PubMed
  43. Joshi M, Cook J, McCullough K, Nanaa A, Gangat N, Foran JM, Murthy HS, Kharfan-Dabaja MA, Sproat L, Palmer J, Pardanani A, Tefferi A, Begna K, Elliot M, Al-Kali A, Patnaik M, Shah MV, Hogan WJ, Litzow MR, Alkhateeb HB. Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation. Blood Cancer J 2021 Mar 4; 11 (3):49 Epub 2021 Mar 04
    View PubMed
  44. Cook J, Johnson I, Higgins A, Sidana S, Warsame R, Gonsalves W, Gertz MA, Buadi F, Lacy M, Kapoor P, Dispenzieri A, Kourelis T, Dingli D, Fonder A, Hayman S, Hobbs M, Hwa YL, Kyle R, Leung N, Go R, Rajkumar VS, Kumar S. Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma. Am J Hematol. 2021 Mar 1; 96 (3):330-337 Epub 2021 Jan 13
    View PubMed
  45. Pitel BA, Sharma N, Zepeda-Mendoza C, Smadbeck JB, Pearce KE, Cook JM, Vasmatzis G, Sachs Z, Kanagal-Shamanna R, Viswanatha D, Xiao S, Jenkins RB, Xu X, Hoppman NL, Ketterling RP, Peterson JF, Greipp PT, Baughn LB. Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis. Blood Cancer J 2021 Feb 8; 11 (2):18 Epub 2021 Feb 08
    View PubMed
  46. Cook J, Acosta-Medina AA, Peng KW, Lacy M, Russell S. Oncolytic virotherapy - Forging its place in the immunomodulatory paradigm for Multiple Myeloma. Cancer Treat Res Commun. 2021; 29:100473 Epub 2021 Oct 09
    View PubMed
  47. Morsia E, McCullough K, Joshi M, Cook J, Alkhateeb HB, Al-Kali A, Begna K, Elliott M, Hogan W, Litzow M, Shah M, Pardanani A, Patnaik M, Tefferi A, Gangat N. Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients. Am J Hematol. 2020 Dec; 95 (12):1511-1521 Epub 2020 Sept 16
    View PubMed
  48. Cook J, Litzow M. Advances in Supportive Care for Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep. 2020 Aug; 15 (4):276-293
    View PubMed
  49. Cook J, Muchtar E, Warsame R. Updates in the Diagnosis and Management of AL Amyloidosis. Curr Hematol Malig Rep. 2020 Jun; 15 (3):155-167
    View PubMed
  50. Duma N, Durani U, Woods CB, Kankeu Fonkoua LA, Cook JM, Wee C, Fuentes HE, Gonzalez-Velez M, Murphy MC, Jain S, Marshall AL, Graff SL, Knoll MA. Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference. J Clin Oncol. 2019 Dec 20; 37 (36):3538-3545 Epub 2019 Oct 11
    View PubMed
  51. Barrett-Campbell O, Cook J, Brown J, Taiwo E, McFarlane SI. Tumor Lysis Syndrome after Hepatic Artery Embolization in a Patient with Neuroendocrine Tumor of Unknown Primary. Am J Med Case Rep. 2019; 7 (7):135-137 Epub 2019 June 24
    View PubMed
  52. Song S, Cook J, Goulbourne C, Meade M, Salciccioli L, Lazar J. First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab. Case Rep Cardiol. 2017; 2017:6458636 Epub 2017 June 14
    View PubMed
  53. Cook J, Song S, Ventimiglia A, Luhrs C. Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction. Case Rep Hematol. 2017; 2017:4531858 Epub 2017 July 06
    View PubMed
  54. Maharaj A, Cook J, Lalchan SA, Suite M, Barrow S. Sarcoid Tattoo Granuloma and Ocular Sarcoidosis: The Great Masquerader West Indian Medical Journal. 2016.
  55. Cook J, Hardie R, Bailey K, Tapper M, Vickers I, Calder D, Harvey K, Lindo JF. Seroprevalence of human toxocariasis, Jamaica. Trop Biomed. 2016 Mar 1; 33 (1):88-94
    View PubMed
  56. Reynolds-Campbell G, Nicholson A, Christian N, Hardie R, Cook J. Aminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods. West Indian Med J. 2015 Mar; 64 (2):87-91 Epub 2015 Feb 12
    View PubMed